MUMBAI Generic drugmaker Wockhardt Ltd (WCKH.NS) on Tuesday said its quarterly net profit plunged 94 percent, as U.S. Food and Drug Administration bans on its manufacturing plants continued to take a toll.
Wockhardt's April-June net profit was 199.5 million rupees($3.26 million), compared with 3.23 billion rupees a year earlier.
Net sales slumped 27 percent to 9.91 billion rupees.
The United States is Wockhardt's biggest market and the FDA has banned the import of generic drugs from two of the company's plants in India, citing quality lapses in the manufacturing process.
In May, the company said the FDA had also expressed concerns over production processes at its Chicago-based Morton Grove Pharmaceuticals unit, which accounts for more than 50 percent of Wockhardt's sales in the United States.
Wockhardt shares fell 5 percent to 674 rupees by 0627 GMT on Nifty that was up 0.54 percent.
($1 = 61.1700 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Anupama Dwivedi)
Paytm parent One97 says MediaTek to invest $60 million
MUMBAI Taiwan's largest chip designer MediaTek Inc is investing $60 million in India's One97 Communications, valuing the payment services and e-commerce firm at about $5 billion, the company said on Tuesday.
Wall St falls as Apple drags down tech stocks
U.S. stocks were lower in late morning trading on Tuesday as Apple dragged down technology stocks after EU antitrust regulators ordered the company to pay about $14.5 billion in back taxes to the Irish government.
Google cloud unit close to winning PayPal business - CNBC
Alphabet Inc's Google is close to winning PayPal Holdings Inc as a client for its cloud business, potentially beating out Amazon.com Inc and Microsoft Corp, CNBC reported on Tuesday.